HURA

Tuhura Biosciences Stock Analysis

AI Rating

Neutral
  • Quality1/10
  • Growth 5/10
  • Value 5/10
Tuhura Biosciences sales and earnings growth
HURA Growth
Neutral
  • Revenue Y/Y 0.00%
  • EPS Y/Y -99.75%
  • FCF Y/Y -33.35%
Tuhura Biosciences gross and profit margin trends
HURA Profitability
Low
  • Gross margin 0.00%
  • EPS margin 0.00%
  • ROIC 5Y 113111.08%
Tuhura Biosciences net debt vs free cash flow
HURA Risk
Great
  • Debt / Equity 0.0
  • Debt / FCF 0.0
  • Interest coverage -11.6

Tuhura Biosciences stock volatility is in-line with the overall market. We give it a Great risk rating.

More Biotechnology stocks ↗